Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
Yellow fever
Adults
2022
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(251)
Topics
Available to download in languages
Regions
Africa
(7)
Americas
(4)
Eastern Mediterranean
(1)
Europe
(1)
South-East Asia
(2)
Western Pacific
(6)
Countries
Diseases
COVID-19
(243)
Pneumococcal disease
(8)
Yellow fever
(2)
Cholera
(1)
Hepatitis A
(1)
Hepatitis B
(4)
Herpes zoster
(4)
HIV / AIDS
(2)
Human papillomavirus (HPV)
(23)
Influenza
(20)
Measles
(1)
Mumps
(1)
Rubella
(1)
Smallpox
(1)
Tetanus
(1)
Tuberculosis
(1)
Zika
(1)
Vaccine topics
Acceptance
(22)
Administration
(35)
Coverage
(2)
Economic aspects
(1)
Efficacy/effectiveness
(79)
Ethical issues
(1)
Safety
(140)
Target population
Adults
(252)
Adolescents
(104)
All age groups
(225)
Children
(46)
Healthcare workers
(75)
Newborn
(20)
Older adults
(196)
Parents/caregivers
(18)
Pregnant women
(45)
Risk group
(1)
Travellers
(2)
Publication date
2022
(252)
2023
(74)
2021
(120)
2020
(61)
2019
(3)
2018
(3)
2017
(7)
2016
(8)
2015
(3)
2014
(4)
2013
(2)
2012
(3)
2011
(1)
252 results found
2022
∙
Araújo Lagos, L. W. Jesus Lopes de Abreu, A. Caetano, R. Braga, J. U.
Yellow fever vaccine safety in immunocompromised individuals: a systematic review and meta-analysis
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register